Trademark Overview
On Friday, January 2, 2026, a trademark application was filed for PROVIA with the United States Patent and Trademark Office. The USPTO has given the PROVIA trademark a serial number of 99575283. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, May 28, 2026. This trademark is owned by MiMedx Group, Inc.. The PROVIA trademark is filed in the Pharmaceutical Products category with the following description:
Human biological amniotic membrane tissue intended for subsequent implantation; biologic drugs for treating inflammation and pain using regenerative tissue components; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a micronized powder comprising amniotic material for medical purposes; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material
